Overview

Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain

Status:
Withdrawn
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical performance of the ReLeaf infusion catheter & wound drain in patients following lumbar spinal fusion surgery. One half of the patients will receive continuous local analgesic fusion during the post-operative period while the other half will received continuous local saline.
Phase:
N/A
Details
Lead Sponsor:
Vital 5, LLC
Treatments:
Analgesics
Morphine
Oxycodone
Ropivacaine